Author:
Williet Nicolas,Boschetti Gilles,Fovet Marion,Di Bernado Thomas,Claudez Pierre,Del Tedesco Emilie,Jarlot Camille,Rinaldi Leslie,Berger Anne,Phelip Jean-Marc,Flourie Bernard,Nancey Stéphane,Paul Stéphane,Roblin Xavier
Subject
Gastroenterology,Hepatology
Reference11 articles.
1. Commissioner of the United Food Administration. FDA approves Entyvio to treat ulcerative colitis and Crohn’s disease. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm398065.htm. Accessed May 17, 2016.
2. European Medicines Agency - Find medicine - Entyvio. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002782/human_med_001751.jsp&mid=WC0b01ac058001d124. Accessed May 17, 2016.
3. Vedolizumab as induction and maintenance therapy for Crohn’s disease;Sandborn;N Engl J Med,2013
4. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013
5. Vedolizumab for ulcerative colitis and Crohn’s disease: results and implications of GEMINI studies;Lam;Immunotherapy,2014
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献